Nektar Therapeutics (NKTR) Accounts Payables: 2010-2024
Historic Accounts Payables for Nektar Therapeutics (NKTR) over the last 15 years, with Dec 2024 value amounting to $11.6 million.
- Nektar Therapeutics' Accounts Payables rose 81.45% to $15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year increase of 81.45%. This contributed to the annual value of $11.6 million for FY2024, which is 17.38% up from last year.
- According to the latest figures from FY2024, Nektar Therapeutics' Accounts Payables is $11.6 million, which was up 17.38% from $9.8 million recorded in FY2023.
- In the past 5 years, Nektar Therapeutics' Accounts Payables registered a high of $22.1 million during FY2020, and its lowest value of $9.7 million during FY2021.
- In the last 3 years, Nektar Therapeutics' Accounts Payables had a median value of $11.6 million in 2024 and averaged $11.5 million.
- In the last 5 years, Nektar Therapeutics' Accounts Payables tumbled by 55.97% in 2021 and then soared by 33.17% in 2022.
- Nektar Therapeutics' Accounts Payables (Yearly) stood at $22.1 million in 2020, then crashed by 55.97% to $9.7 million in 2021, then soared by 33.17% to $13.0 million in 2022, then dropped by 24.13% to $9.8 million in 2023, then increased by 17.38% to $11.6 million in 2024.